mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.4 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |